BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28894001)

  • 1. Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development.
    Yu H; Gagliani N; Ishigame H; Huber S; Zhu S; Esplugues E; Herold KC; Wen L; Flavell RA
    Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10443-10448. PubMed ID: 28894001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of New Onset Type 1 Diabetes by Oral
    Mbongue JC; Rawson J; Garcia PA; Gonzalez N; Cobb J; Kandeel F; Ferreri K; Husseiny MI
    Front Immunol; 2019; 10():320. PubMed ID: 30863412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-10 Deficiency Accelerates Type 1 Diabetes Development
    Huang J; Tan Q; Tai N; Pearson JA; Li Y; Chao C; Zhang L; Peng J; Xing Y; Zhang L; Hu Y; Zhou Z; Wong FS; Wen L
    Front Immunol; 2021; 12():702955. PubMed ID: 34394099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different modulation of Ptpn22 in effector and regulatory T cells leads to attenuation of autoimmune diabetes in transgenic nonobese diabetic mice.
    Yeh LT; Miaw SC; Lin MH; Chou FC; Shieh SJ; Chuang YP; Lin SH; Chang DM; Sytwu HK
    J Immunol; 2013 Jul; 191(2):594-607. PubMed ID: 23752610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.
    Kutukculer N; Azarsiz E; Aksu G; Karaca NE
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):241-51. PubMed ID: 26684629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
    Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
    PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7.
    Szanya V; Ermann J; Taylor C; Holness C; Fathman CG
    J Immunol; 2002 Sep; 169(5):2461-5. PubMed ID: 12193715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.
    Esensten JH; Lee MR; Glimcher LH; Bluestone JA
    J Immunol; 2009 Jul; 183(1):75-82. PubMed ID: 19535634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance.
    Gregg RK; Bell JJ; Lee HH; Jain R; Schoenleber SJ; Divekar R; Zaghouani H
    J Immunol; 2005 Jan; 174(2):662-70. PubMed ID: 15634884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo.
    Tonkin DR; He J; Barbour G; Haskins K
    J Immunol; 2008 Oct; 181(7):4516-22. PubMed ID: 18802054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.
    Brown K; Godovannyi A; Ma C; Zhang Y; Ahmadi-Vand Z; Dai C; Gorzelak MA; Chan Y; Chan JM; Lochner A; Dutz JP; Vallance BA; Gibson DL
    ISME J; 2016 Feb; 10(2):321-32. PubMed ID: 26274050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective.
    Yu H; Paiva R; Flavell RA
    Immunology; 2018 Feb; 153(2):161-170. PubMed ID: 29155454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex dietary polysaccharide modulates gut immune function and microbiota, and promotes protection from autoimmune diabetes.
    Gudi R; Perez N; Johnson BM; Sofi MH; Brown R; Quan S; Karumuthil-Melethil S; Vasu C
    Immunology; 2019 May; 157(1):70-85. PubMed ID: 30712258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventative role of interleukin-17 producing regulatory T helper type 17 (Treg 17) cells in type 1 diabetes in non-obese diabetic mice.
    Bellemore SM; Nikoopour E; Schwartz JA; Krougly O; Lee-Chan E; Singh B
    Clin Exp Immunol; 2015 Dec; 182(3):261-9. PubMed ID: 26250153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease.
    Alfen JS; Larghi P; Facciotti F; Gagliani N; Bosotti R; Paroni M; Maglie S; Gruarin P; Vasco CM; Ranzani V; Frusteri C; Iseppon A; Moro M; Crosti MC; Gatti S; Pagani M; Caprioli F; Abrignani S; Flavell RA; Geginat J
    J Allergy Clin Immunol; 2018 Nov; 142(5):1537-1547.e8. PubMed ID: 29369775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
    Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
    J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Presence and Preferential Activation of Regulatory T Cells Diminish Adoptive Transfer of Autoimmune Diabetes by Polyclonal Nonobese Diabetic (NOD) T Cell Effectors into NSG versus NOD-scid Mice.
    Presa M; Chen YG; Grier AE; Leiter EH; Brehm MA; Greiner DL; Shultz LD; Serreze DV
    J Immunol; 2015 Oct; 195(7):3011-9. PubMed ID: 26283479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.
    Wu C; Pan LL; Niu W; Fang X; Liang W; Li J; Li H; Pan X; Chen W; Zhang H; Lakey JRT; Agerberth B; de Vos P; Sun J
    Front Immunol; 2019; 10():1733. PubMed ID: 31417546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.